TI
MRNA icon

Trexquant Investment’s Moderna MRNA Stock Holding History

Trexquant Investment’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.4M Buy
505,160
+21,189
+4% +$1.1M 0.21% 69
2026
Q1 		$24.6M Buy
+483,971
New +$22.6M 0.18% 111
2025
Q4 		– Sell
-299,938
Closed -$7.75M – 1809
2025
Q3 		$7.75M Buy
299,938
+142,607
+91% +$3.98M 0.08% 384
2025
Q2 		$4.34M Buy
+157,331
New +$4.14M 0.05% 585
2024
Q3 		– Sell
-89,181
Closed -$10.6M – 1752
2024
Q2 		$10.6M Buy
+89,181
New +$11.3M 0.16% 169
2023
Q4 		– Sell
-69,724
Closed -$7.2M – 1660
2023
Q3 		$7.2M Buy
69,724
+55,056
+375% +$6.14M 0.18% 147
2023
Q2 		$1.78M Sell
14,668
-119,919
-89% -$16M 0.05% 529
2023
Q1 		$20.7M Buy
+134,587
New +$22.2M 0.57% 16
2022
Q3 		– Sell
-50,072
Closed -$7.15M – 1679
2022
Q2 		$7.15M Buy
+50,072
New +$7.16M 0.32% 67
2022
Q1 		– Sell
-41,922
Closed -$10.6M – 1600
2021
Q4 		$10.6M Buy
41,922
+30,738
+275% +$8.99M 0.66% 12
2021
Q3 		$4.3M Buy
11,184
+9,626
+618% +$3.55M 0.34% 61
2021
Q2 		$366K Sell
1,558
-37,838
-96% -$6.76M 0.03% 624
2021
Q1 		$5.16M Buy
39,396
+11,820
+43% +$1.71M 0.47% 34
2020
Q4 		$2.88M Buy
+27,576
New +$2.79M 0.31% 81
2020
Q3 		– Sell
-68,456
Closed -$4.4M – 1430
2020
Q2 		$4.4M Buy
+68,456
New +$3.75M 0.31% 71
2020
Q1 		– Sell
-23,786
Closed -$465K – 1303
2019
Q4 		$465K Buy
+23,786
New +$422K 0.03% 584

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Trexquant Investment's MRNA Position: Q2 2026 in Review

Trexquant Investment increased its Moderna (MRNA) stake by 4.4% in Q2 2026, buying an estimated $1.1M and bringing the position to 505,160 shares worth $35.4M. The position accounts for 0.21% of the portfolio, ranked #69.

Trexquant Investment first reported a position in MRNA in Q4 2019 and has held it in 16 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Trexquant Investment held 505,160 shares of Moderna worth $35.4M as of Q2 2026.
  • Trexquant Investment bought 21,189 Moderna shares in Q2 2026, an estimated $1.1M.
  • Moderna made up 0.21% of Trexquant Investment's portfolio in Q2 2026, its #69 holding.
  • Trexquant Investment first reported a position in Moderna in Q4 2019 and has held it in 16 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.